Interazioni tra farmaci
Amivantamab + Lazertinib
Gravità: Moderata
Amivantamab and Lazertinib: moderate interaction.
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
Sintesi
Amivantamab with lazertinib raises the risk of venous thromboembolism, and prophylaxis is recommended. Vitamin K antagonists are poorly suited for this because their variable effect makes control difficult, whereas the interaction concerns the combination's thrombotic risk.
Cosa significa questa interazione in parole semplici
Amivantamab and Lazertinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Amivantamab belongs to Oncology; Lazertinib belongs to Oncology.
Perché avviene
The combination increases thromboembolic risk by an incompletely established mechanism.
Cosa fare
Give anticoagulant prophylaxis during the first months of therapy, preferably with a direct oral anticoagulant or low molecular weight heparin rather than a vitamin K antagonist. Monitor for signs of VTE.
Cosa chiedere al farmacista
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Amivantamab e Lazertinib, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Domande frequenti
Can I take Amivantamab with Lazertinib?
MediHelp rates the interaction as moderate. Amivantamab and Lazertinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Amivantamab with lazertinib raises the risk of venous thromboembolism, and prophylaxis is recommended. Vitamin K antagonists are poorly suited for this because their variable effect makes control difficult, whereas the interaction concerns the combination's thrombotic risk.
How serious is the interaction between Amivantamab and Lazertinib?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Give anticoagulant prophylaxis during the first months of therapy, preferably with a direct oral anticoagulant or low molecular weight heparin rather than a vitamin K antagonist. Monitor for signs of VTE.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
